menu
    • menu

    Company profile for Fortress Biotech

    NEW Drugs in Dev: 5
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Fortress Biotech ("Fortress" or "the Company") is an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential clinical-stage assets. The company has over 25 programs in clinical development at Fortress, at its majority-owned and majority-controlled subsidiaries and at entities it founded and in which it holds significant minority ownership positions. Such product candidates span ...
    Fortress Biotech ("Fortress" or "the Company") is an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential clinical-stage assets. The company has over 25 programs in clinical development at Fortress, at its majority-owned and majority-controlled subsidiaries and at entities it founded and in which it holds significant minority ownership positions. Such product candidates span six large-market therapeutic areas, including oncology, rare diseases and gene therapy, which allow it to create value while mitigating risk for shareholders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Fortress BiotechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2 Gansevoort Street, 9th Floor New York, NY 10014
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.fortressbiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/fortress-biotech/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/fortressbio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    MAGHREB Pharma Expo

    MAGHREB Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    MAGHREB Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fortress Biotech Unveils 2025 Financials And Key Updates
    Fortress Biotech Unveils 2025 Financials And Key Updates

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3266013/28889/en/Fortress-Biotech-Reports-2025-Financial-Results-and-Recent-Corporate-Highlights.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Cyprium Closes Sale for Priority Review Voucher for $205 Million
    Cyprium Closes Sale for Priority Review Voucher for $205 Million

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3265013/28889/en/Fortress-Biotech-s-Subsidiary-Cyprium-Therapeutics-Closes-Sale-of-Rare-Pediatric-Disease-Priority-Review-Voucher-for-205-Million.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Fortress Unit Cyprium Sells Rare Pediatric PRV For $205M
    Fortress Unit Cyprium Sells Rare Pediatric PRV For $205M

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242632/28889/en/Fortress-Biotech-s-Subsidiary-Cyprium-Therapeutics-Enters-into-Agreement-to-Sell-Rare-Pediatric-Disease-Priority-Review-Voucher-for-205-Million.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Fortress Biotech and Cyprium Announce FDA Approve ZYCUBO
    Fortress Biotech and Cyprium Announce FDA Approve ZYCUBO

    12 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211241

    FDA
    12 Jan 2026
    Share Share
    Fortress Biotech, Cyprium Therapeutics Announce FDA Acceptance
    Fortress Biotech, Cyprium Therapeutics Announce FDA Acceptance

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205379/28889/en/Fortress-Biotech-and-Cyprium-Therapeutics-Announce-FDA-Acceptance-of-CUTX-101-NDA-Resubmission.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Fortress Biotech Unveils Q3 2025 Financials & Corporate Updates
    Fortress Biotech Unveils Q3 2025 Financials & Corporate Updates

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188314/28889/en/Fortress-Biotech-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Highlights.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search